Figure 1.
Mean postprandial glucose (±SEM) of participants with a monophasic curve shape during the control and treatment visits with (a) 50 and (b) 400 mg of Enzogenol®. * p < 0.05 for 400 mg Enzogenol® compared to control.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.